Sensus outlines shift to $250,000 average selling price as it targets a stronger second half (NASDAQ:SRTS)


Earnings Call Insights: Sensus Healthcare (SRTS) Q2 2026

Management View

  • “During the quarter, we secured equipment orders that we expected to be recognized in Q2. Third-party financing approval was not completed before June 30… which prevented us from recognizing 19 units and related

Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.



Source link

Your valley smells like closet.

‘All That’ Star Passes Away At Age 46

Leave a Reply

Your email address will not be published. Required fields are marked *